APTEVO THERAPEUTICS INC. APVO Income Statement

Aptevo therapeutics inc. (APVO)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Sep'15	Jun'15
Operating expenses:
Revenues:
Product sales
-	-	29,739	26,552	-	23,067	0	0	0	-	0	0	-	-	-	-	-	-	-
Product sales
-	-	-	-	-	-	-	-	-	-	-	-	3,971	9,805	0	0	0	0	0
Collaborations
-	-	-	-	-	-	-	-	-	-	-	-	89	180	0	0	0	-	-
Contracts, grants and collaborations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Total revenues
-	-	-	-	-	-	-	-	-	-	-	-	4,060	9,985	0	0	0	0	0
Costs and expenses:
Cost of product sales
-	-	18,253	16,731	-	11,214	0	0	0	-	-	-	-	-	-	-	-	-	-
Cost of product sales
-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-
Cost of product sales
-	-	-	-	-	-	-	-	-	-	-	-	-	12,467	0	0	0	0	0
Research and development
27,129	29,757	32,391	31,840	33,820	35,385	35,672	34,273	31,347	29,021	26,141	26,043	26,892	29,120	0	0	0	0	0
General and administrative
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses:
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, general and administrative
-	-	26,922	27,386	-	28,133	30,111	30,644	32,041	34,576	32,760	36,428	36,866	36,158	0	0	0	0	0
Impairment of goodwill and intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Loss from operations
-	-	-48,478	-50,056	-	-51,665	-54,893	-53,114	-55,319	-53,949	-59,550	-139,727	-137,923	-138,773	0	0	0	0	0
Other expense from continuing operations
-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Other expense from continuing operations
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-
Other expense:
Other expense, net
0	-	-	0	0	-	-	0	0	-	-	-	-	-810	0	0	0	0	0
Loss on extinguishment of debt
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total other expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-810	0	0	0	0	0
Loss before income tax
-	-	0	-	-	-	0	-	-	-55,893	-61,300	-141,533	-139,219	-139,583	0	0	0	0	0
Benefit from income tax
-	-	0	-	-	-	-	-	-	-23,301	-17,648	-21,488	-20,503	-19,692	0	0	0	0	0
Net loss from continuing operations
0	-	0	-	0	-	0	-	-	-32,592	0	0	0	-	0	-	-	-	-
Discontinued operations (Note 2):
Income from discontinued operations, before income taxes
-	-	0	-	-	-	-	-	-	62,864	0	0	0	-	0	-	-	-	-
Income tax expense
-	-	0	-	-	-	-	-	-	23,299	0	0	0	-	0	-	-	-	-
Income (loss) from discontinued operations
0	-	0	-	0	-	-	-	-	39,565	0	0	0	-	0	-	-	-	-
Net income (loss)
-25,533	-40,448	-46,403	-52,041	-51,853	-53,689	-49,320	1,109	3,064	6,973	1,786	-107,822	-109,471	-112,415	0	0	0	0	0
Basic and diluted net income (loss) per share:
Net loss from continuing operations
-3.06	-	-0.23	-	-7.46	-	-0.55	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) from discontinued operations
3.94	-	0.07	-	-0.18	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net (loss) income from continuing operations
-	-	-	-	-	-	-	-	-	-	0.14	-0.67	-0.56	-	-3.63	-	-	-	-
Net income from discontinued operations
-	-	-	-	-	-	-	-	-	-	1.63	0.14	0.08	-	0.08	-	-	-	-
Net loss per basic share
-	-	-0.16	-	-	-	-0.55	-	-	-	1.77	-0.53	-0.48	-	-3.55	-	-	-	-
Weighted-average shares used to compute per share calculations
-	-	-	-	-	-	-	-	-	-	21,385	21,265	20,757	-	20,235	-	-	-	-
Net (loss) income from continuing operations
-	-	-	-	-	-	-	-	-	-	0.14	-	-	-	-3.63	-	-	-	-
Net income from discontinued operations
-	-	-	-	-	-	-	-	-	-	1.61	-	-	-	0.08	-	-	-	-
Net (loss) income per diluted share
-	-	-	-	-	-	-	-	-	-	1.75	-	-	-	-3.55	-	-	-	-
Weighted-average shares used to compute per share calculations
-	-	-	-	-	-	-	-	-	-	21,672	-	-	-	20,235	-	-	-	-
Comprehensive loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Basic and diluted net income (loss) per basic share
0.89	-	-	-0.30	-7.64	-	-	-0.58	-0.63	-	-	-	-	-	-	-0.63	-0.64	-0.63	-0.88
Weighted-average shares used to compute per share calculations
3,270	71,515	45,169	45,095	1,573	22,713	22,672	22,588	22,025	-	-	-	-	-	-	20,229	20,229	20,229	20,229